(A) Fetal thrombocytopenia due to maternal anti–HPA-1a alloantibodies. (B) Fetal platelets protected from alloantibody-mediated destruction by modified anti–HPA-1a antibodies that bind to fetal platelets but do not cause phagocytosis. Professional illustration by Alice Y. Chen.